Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. GOOGL
5. MU
6. DFTX
7. USO
8. APGE
9. ABBV
10. NAVN

Go back to Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study
Pfizer Inc. (NYSE: PFE) Delayed: 25.08 --0 (-0%)
Previous Close $25.08    52 Week High $37.39 
Open $25.08    52 Week Low $28.25 
Day High $25.08    P/E 15.20 
Day Low $25.08    EPS $1.65 
Volume 151,191